Literature DB >> 29790130

An Analysis of Mid-Term Complications, Weight Loss, and Type 2 Diabetes Resolution of Stomach Intestinal Pylorus-Sparing Surgery (SIPS) Versus Roux-En-Y Gastric Bypass (RYGB) with Three-Year Follow-Up.

Austin Cottam1, Daniel Cottam2, Hinali Zaveri1, Samuel Cottam1, Amit Surve1, Walter Medlin1, Christina Richards1.   

Abstract

BACKGROUND: For many years, the Roux-en-Y Gastric Bypass (RYGB) was considered a good balance of complications and weight loss. According to several short-term studies, single anastomosis duodenal switch or stomach intestinal pylorus sparing surgery (SIPS) offers similar weight loss to RYGB with fewer complications and better diabetes resolution. No one has substantiated mid-term complication and nutritional differences between these two procedures. This paper seeks to compare complication and nutritional outcomes between RYGB and SIPS.
METHODS: A retrospective analysis of 798 patients who either had SIPS or RYGB from 2010 to 2016. Complications were gathered for each patient. Nutritional outcomes were measured for each group at 1, 2, and 3 years. Regression analysis was applied to interpolate each patient's weight at 3, 6, 9, 12, 18, 24, and 36 months. These were then compared with t tests, Fisher's exact tests, and chi-squared tests.
RESULTS: RYGB and SIPS have statistically similar weight loss at 3, 6, 9, 12, and 36 months. They statistically differ at 18 and 24 months. At 36 months, there is a trend for weight loss difference. There were only statistical differences in nutritional outcomes between the two procedures with calcium at 1 and 3 years and vitamin D at 1 year. There were statistically significantly more long-term class IIIb-V complications, class I-IIIa complications, reoperations, ulcers, small bowel obstructions, nausea, and vomiting with the RYGB than the SIPS.
CONCLUSION: With comparable weight loss and nutritional outcomes, SIPS has fewer short- and long-term complications than RYGB and better type 2 diabetes resolution rates.

Entities:  

Keywords:  Bariatric Surgery; Complication Comparisons; Diabetes; Diabetes Resolution; Gastric Bypass; RYGB; Roux-en-Y Gastric Bypass; SADI-S; SIPS; Single Anastomosis Duodeno–Ileal Bypass with Sleeve Gastrectomy; Stomach Intestinal Pylorus Sparing Surgery; T2DM

Mesh:

Year:  2018        PMID: 29790130     DOI: 10.1007/s11695-018-3309-6

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  37 in total

1.  Internal hernia after revisional laparoscopic loop duodenal switch surgery.

Authors:  Christina Summerhays; Daniel Cottam; Austin Cottam
Journal:  Surg Obes Relat Dis       Date:  2015-08-29       Impact factor: 4.734

2.  Single-anastomosis duodenoileal bypass with sleeve gastrectomy: metabolic improvement and weight loss in first 100 patients.

Authors:  Andrés Sánchez-Pernaute; Miguel Ángel Rubio; Elia Pérez Aguirre; Ana Barabash; Lucio Cabrerizo; Antonio Torres
Journal:  Surg Obes Relat Dis       Date:  2012-08-07       Impact factor: 4.734

Review 3.  Rate of Death and Complications in Laparoscopic and Open Roux-en-Y Gastric Bypass. A Meta-analysis and Meta-regression Analysis on 69,494 Patients.

Authors:  Emanuele Rausa; Luigi Bonavina; Emanuele Asti; Maddalena Gaeta; Cristian Ricci
Journal:  Obes Surg       Date:  2016-08       Impact factor: 4.129

4.  Laparoscopic Sleeve Gastrectomy and Gastric Bypass for The Aging Population.

Authors:  James Yoon; Jingjing Sherman; Alexandra Argiroff; Edward Chin; Daniel Herron; William Inabnet; Subhash Kini; Scott Nguyen
Journal:  Obes Surg       Date:  2016-11       Impact factor: 4.129

5.  Long-term success and failure with SG is predictable by 3 months: a multivariate model using simple office markers.

Authors:  Austin Cottam; Josiah Billing; Daniel Cottam; Peter Billing; Samuel Cottam; Hinali Zaveri; Amit Surve
Journal:  Surg Obes Relat Dis       Date:  2017-03-23       Impact factor: 4.734

6.  Single-anastomosis duodenoileal bypass as a second step after sleeve gastrectomy.

Authors:  Andrés Sánchez-Pernaute; Miguel Ángel Rubio; María Conde; Emmy Arrue; Elia Pérez-Aguirre; Antonio Torres
Journal:  Surg Obes Relat Dis       Date:  2014-07-10       Impact factor: 4.734

7.  Weight loss at first postoperative visit predicts long-term outcome of Roux-en-Y gastric bypass using Duke weight loss surgery chart.

Authors:  Alessandro Mor; Lindsey Sharp; Dana Portenier; Ranjan Sudan; Alfonso Torquati
Journal:  Surg Obes Relat Dis       Date:  2012-07-16       Impact factor: 4.734

8.  Stomach Intestinal Pylorus Sparing (SIPS) Surgery for Morbid Obesity: Retrospective Analyses of Our Preliminary Experience.

Authors:  Brian Mitzman; Daniel Cottam; Richie Goriparthi; Samuel Cottam; Hinali Zaveri; Amit Surve; Mitchell S Roslin
Journal:  Obes Surg       Date:  2016-09       Impact factor: 4.129

9.  Correlation between age and weight loss after bariatric surgery.

Authors:  Juan Eduardo Contreras; Carmen Santander; Ismael Court; Jorge Bravo
Journal:  Obes Surg       Date:  2013-08       Impact factor: 4.129

Review 10.  Anaemia and related nutrient deficiencies after Roux-en-Y gastric bypass surgery: a systematic review and meta-analysis.

Authors:  Ting-Chia Weng; Chia-Hsuin Chang; Yaa-Hui Dong; Yi-Cheng Chang; Lee-Ming Chuang
Journal:  BMJ Open       Date:  2015-07-16       Impact factor: 2.692

View more
  9 in total

1.  Single Anastomosis Duodenal-Ileal Bypass with Sleeve Gastrectomy/One Anastomosis Duodenal Switch (SADI-S/OADS) IFSO Position Statement-Update 2020.

Authors:  Wendy A Brown; Guillermo Ponce de Leon Ballesteros; Geraldine Ooi; Kelvin Higa; Jacques Himpens; Antonio Torres; Scott Shikora; Lilian Kow; Miguel F Herrera
Journal:  Obes Surg       Date:  2021-01-06       Impact factor: 4.129

2.  Reduced expression of microRNA-199a-3p is associated with vascular endothelial cell injury induced by type 2 diabetes mellitus.

Authors:  Hui Wang; Zhengxia Wang; Qingbin Tang
Journal:  Exp Ther Med       Date:  2018-08-24       Impact factor: 2.447

3.  Retrospective Comparison of SADI-S Versus RYGB in Chinese with Diabetes and BMI< 35kg/m2: a Propensity Score Adjustment Analysis.

Authors:  Qing Sang; Liang Wang; Qiqige Wuyun; Xuejing Zheng; Dezhong Wang; Nengwei Zhang; Dexiao Du
Journal:  Obes Surg       Date:  2021-09-30       Impact factor: 4.129

4.  Sleeve Gastrectomy with Bypass of Proximal Small Intestine Provides Better Diabetes Control than Sleeve Gastrectomy Alone Under Postoperative High-Fat Diet.

Authors:  Yugang Cheng; Xin Huang; Dong Wu; Qiaoran Liu; Mingwei Zhong; Teng Liu; Xiang Zhang; Guangyong Zhang; Sanyuan Hu; Shaozhuang Liu
Journal:  Obes Surg       Date:  2019-01       Impact factor: 4.129

5.  Single Anastomosis Duodenal Switch: 1-Year Outcomes.

Authors:  Daniel Cottam; Mitchell Roslin; Paul Enochs; Matthew Metz; Dana Portenier; Dennis Smith
Journal:  Obes Surg       Date:  2020-04       Impact factor: 4.129

6.  A Multi-institutional Study on the Mid-Term Outcomes of Single Anastomosis Duodeno-Ileal Bypass as a Surgical Revision Option After Sleeve Gastrectomy.

Authors:  Hinali Zaveri; Amit Surve; Daniel Cottam; Peter C Ng; Paul Enochs; Helmuth Billy; Walter Medlin; Christina Richards; LeGrand Belnap; Lindsey S Sharp; Dustin M Bermudez; Ryan Fairley; Tricia A Burns; Krista Herrell; Jaime Bull; Sophia E Menozzi; John Ambrose Student
Journal:  Obes Surg       Date:  2019-10       Impact factor: 4.129

7.  Comparison of Diabetes Remission and Micronutrient Deficiency in a Mildly Obese Diabetic Rat Model Undergoing SADI-S Versus RYGB.

Authors:  Tingfeng Wang; Yunlong Shen; Zhengdong Qiao; Yueqian Wang; Peng Zhang; Bo Yu
Journal:  Obes Surg       Date:  2019-04       Impact factor: 4.129

8.  Current and future impact of clinical gastrointestinal research on patient care in diabetes mellitus.

Authors:  Timothy R Koch; Timothy R Shope; Michael Camilleri
Journal:  World J Diabetes       Date:  2018-11-15

9.  Roux-en-Y Gastric Bypass Improves Hepatic Glucose Metabolism Involving Upregulation of Sirt1 in Type 2 Diabetes Mellitus.

Authors:  Chunjie Su; Qian Cheng; Liyun Wang
Journal:  Diabetes Metab Syndr Obes       Date:  2021-05-20       Impact factor: 3.168

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.